Favorable clinical responses have been demonstrated in cutaneous T-cell lymphoma with emerging evidence of clinical activity in other types of lymphoma and, to date, a good toxicity profile.

Get Instant Summarized Text (Gist) A clinical trial demonstrated that combining chemotherapy with immunotherapy significantly improves treatment outcomes for diffuse large B-cell lymphoma (DLBCL ...

SGX301 has led positive results in early-stage CTCL, with over 70% achieving treatment success in the phase 3 FLASH study. The phase 3 FLASH (NCT02448381) study evaluating SGX301 (HyBryte) has shown ...

T-cell skin lymphomas are more common than B-cell skin lymphomas. T-Cell Skin Lymphoma Cutaneous T-cell lymphoma (CTCL) occurs when a mutation causes the cell to divide too quickly and stay alive too ...

The American Cancer Society’s most recent estimates for all types of non-Hodgkin lymphoma (NHL) in the United States for 2025 are: 80,350 new cases of NHL (45,140 in men and 35,210 in women) 19,390 ...

With limited treatment options, especially in the early stages of their disease, CTCL patients are often searching for alternative treatments. In our U.S. Food and Drug Administration (FDA)-funded ...

Jiangsu Key Laboratory of Drug Design and Optimization and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China Jiangsu Key Laboratory of Drug Design and ...

Phototherapy involves the use of ultraviolet light for the treatment of skin disease and many dermatologists have phototherapy units in their offices. With these units, ultraviolet light of ...

eligible tuition and other fees paid to an eligible educational institution in Canada for courses you took in 2024 fees paid to certain bodies in respect of an occupational, trade or professional ...